Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Former Innospec Exec Charged In London

The U.K. Serious Fraud Office said today that a former Innospec business unit director was charged with conspiring to make corrupt payments to public officials in Indonesia and Iraq to secure sales of the company’s products.

Dr David Turner, 56, of Newmarket, Suffolk, was in charge of Innospec’s octane additives unit. He appeared today before the Westminster Magistrates’ Court. His case is transferred to Southwark Crown Court.

He was also charged with conspiring to defraud a competitor company by bribing Iraqi officials to provide unfavourable test results on its product. 

The SFO said the alleged offenses occurred between 2002 and 2008.

Turner was given unconditional bail. He’s scheduled to appear in court on November 2.

In March last year, Innospec — a specialty chemical-maker based in Delaware — reached a $40 million global settlement of more than a dozen criminal charges in the U.S. and U.K., including FCPA and U.N. oil for food program offenses, and violations of the U.S. embargo against Cuba.

Innospec’s agent in Iraq, Ousama Naaman, pleaded guilty in June last year in Washington, D.C. to conspiracy and violating the Foreign Corrupt Practices Act. He was charged in a June 24, 2010 superseding information with engaging in an eight-year conspiracy to defraud the United Nations oil-for-food program and bribing Iraqi officials. He’s waiting to be sentenced.

No Innospec employees have faced criminal charges in the U.S. in the case.

View the SFO’s October 25 release here.

Share this post

LinkedIn
Facebook
Twitter

Comments are closed for this article!